- Home
- OSUR vs LPAA Comparison
OSUR vs LPAA Comparison
Compare OSUR & LPAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OSUR
- LPAA
- Stock Information
- Founded
- OSUR 2000
- LPAA 2024
- Country
- OSUR United States
- LPAA United States
- Employees
- OSUR N/A
- LPAA N/A
- Industry
- OSUR Medical/Dental Instruments
- LPAA
- Sector
- OSUR Health Care
- LPAA
- Exchange
- OSUR Nasdaq
- LPAA Nasdaq
- Market Cap
- OSUR 289.4M
- LPAA 286.9M
- IPO Year
- OSUR 1986
- LPAA 2024
- Fundamental
- Price
- OSUR $3.60
- LPAA N/A
- Analyst Decision
- OSUR Hold
- LPAA
- Analyst Count
- OSUR 2
- LPAA 0
- Target Price
- OSUR $5.50
- LPAA N/A
- AVG Volume (30 Days)
- OSUR 1.0M
- LPAA 59.5K
- Earning Date
- OSUR 11-06-2024
- LPAA 01-01-0001
- Dividend Yield
- OSUR N/A
- LPAA N/A
- EPS Growth
- OSUR N/A
- LPAA N/A
- EPS
- OSUR 0.15
- LPAA N/A
- Revenue
- OSUR $224,263,000.00
- LPAA N/A
- Revenue This Year
- OSUR N/A
- LPAA N/A
- Revenue Next Year
- OSUR N/A
- LPAA N/A
- P/E Ratio
- OSUR $24.43
- LPAA N/A
- Revenue Growth
- OSUR N/A
- LPAA N/A
- 52 Week Low
- OSUR $3.58
- LPAA $9.66
- 52 Week High
- OSUR $8.45
- LPAA $10.05
- Technical
- Relative Strength Index (RSI)
- OSUR 37.25
- LPAA N/A
- Support Level
- OSUR $3.76
- LPAA N/A
- Resistance Level
- OSUR $3.70
- LPAA N/A
- Average True Range (ATR)
- OSUR 0.17
- LPAA 0.00
- MACD
- OSUR -0.03
- LPAA 0.00
- Stochastic Oscillator
- OSUR 0.83
- LPAA 0.00
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.
About LPAA Launch One Acquisition Corp. Class A Ordinary shares
Launch One Acquisition Corp is a blank check company.